Cintas (CTAS) Total Non-Current Liabilities (2010 - 2026)
Cintas (CTAS) posted Total Non-Current Liabilities of $2.7 billion for Q2 2026, down 25.52% sequentially from $3.6 billion in Q1 2026, and down 22.71% YoY from $3.5 billion in Q2 2025.
Cintas (CTAS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cintas has reported Total Non-Current Liabilities for 17 years, with the latest figure at $2.7 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 22.71% year-over-year to $2.7 billion in Q2 2026, while the trailing twelve-month figure through May 2026 was $2.7 billion (down 22.71% YoY) and the FY2026 annual result came in at $2.7 billion, down 22.71% from the prior year.
- Total Non-Current Liabilities slipped to $2.7 billion in Q2 2026 per CTAS's latest filing, from $3.6 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $3.6 billion in Q1 2026 and troughed at $2.3 billion in Q1 2022.
- A 5-year average of $3.3 billion and a median of $3.4 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities slumped 30.96% in 2022, then soared 53.01% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $3.4 billion in 2022, then grew by 0.55% to $3.5 billion in 2023, then declined by 11.44% to $3.1 billion in 2024, then rose by 17.48% to $3.6 billion in 2025, then decreased by 24.97% to $2.7 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.7 billion, $3.6 billion, and $3.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | 2.70 Bn |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | 8.47 Bn |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | 852.28 Mn |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | 38.53 Bn |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | 6.28 Bn |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | 13.32 Bn |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | 1.41 Bn |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | -6.00 Mn |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 477.38 Mn |
| 10 | Unifirst | 5.24 Bn | 5.07 Bn | 234.73 Mn | 493.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2.70 Bn |
| Feb 28, 2026 | 3.63 Bn |
| Nov 30, 2025 | 3.60 Bn |
| Aug 31, 2025 | 3.57 Bn |
| May 31, 2025 | 3.50 Bn |
| Feb 28, 2025 | 3.08 Bn |
| Nov 30, 2024 | 3.07 Bn |
| Aug 31, 2024 | 3.06 Bn |
| May 31, 2024 | 3.02 Bn |
| Feb 29, 2024 | 3.47 Bn |
| Nov 30, 2023 | 3.46 Bn |
| Aug 31, 2023 | 3.47 Bn |
| May 31, 2023 | 3.45 Bn |
| Feb 28, 2023 | 3.44 Bn |
| Nov 30, 2022 | 3.44 Bn |
| Aug 31, 2022 | 3.43 Bn |
| May 31, 2022 | 3.41 Bn |
| Feb 28, 2022 | 2.25 Bn |
| Nov 30, 2021 | 2.28 Bn |
| Aug 31, 2021 | 2.28 Bn |